News | QuaCell Biotechnology announced that it had completed nearly 200 million yuan of round B financing
August 16, 2021
Recently, Quacell Biotechnology Co., Ltd. announced the completion of nearly 200 million yuan of round B financing. This round of investment will be used to strengthen product R & D, improve technological innovation and production capacity as well as high-standard industrial order delivery capacity.
Dr. Poon, CEO of QuaCell Biotechnology, Co., Ltd. was honored to be elected Associate Editor of RE: GEN Open
June 25, 2021
June 25, 2021 / Quacell Newsroom /- Dr. Poon, CEO of Quacell Biotechnology Co., Ltd. was invited by Re: Gen Open to be selected as Associate Editor.
Conclusion | Biofuture2021
May 25, 2021
The two-day Biofuture 2021 Next Generation Antibody Drug Technology Innovation Conference & Cell and Gene Therapy Innovation Conference came to a successful conclusion.
BIG EVENETS. Day 2 | Biofuture 2021
May 21, 2021
Quacell Biotechnology will continue to show you more latest information about our products in the #B21 booth
BIG EVENETS. Day 1 | Biofuture 2021
May 20, 2021
Biofuture 2021 Next Generation Antibody Drug Technology Innovation Conference & Cell and Gene Therapy Innovation Conference held in Crowne Plaza Shanghai Jiangong Pujiang Hotel
Wayne293™ Transient medium was launched
May 11, 2021
Wayne293™ Transient Medium: One-step expression of desired proteins
CHO CD02, CHO CD04, and CHO Feed02 were launched
May 11, 2021
QuaCell Biotechnology’s three new products were officially launched, namely CHO CD02, CHO CD04, and CHO Feed02.
Awarded the Fifth Whampoa Cup "Creating Youth" Guangdong Innovation and Entrepreneurship Competition and the second prize of the first Guangdong-Hong Kong-Macao Greater Bay Area Youth Innovation and Entrepreneurship Group
May 11, 2021
QuaCell Biotechnology relies on "core materials for biological drug research and development and production --the CD medium industrialization project, the core material for biopharmaceutical R&D and production, advanced to the finals in the Fifth "Creating Youth" Guangdong Innovation and Entrepreneurship Competition in the Whampoa Cup 2018 and the first Guangdong-Hong Kong-Macao Greater Bay Area Youth Innovation and Entrepreneurship Competition. Second Prize in the Start-up Group".
Finalist National-Quacell Biotechnology won the Second place in the Biomedical Industry Finals of the 7th China Innovation and Entrepreneurship Competition (Guangdong Division)
May 11, 2021
Yesterday, the 7th China Innovation and Entrepreneurship Competition (Guangdong Division) and the 6th“Pearl Angel Cup” Technology Innovation and Entrepreneurship Competition finals were held in Guangzhou, South China, New Materials Innovation Park.
QuaCell signed strategic cooperation agreement with Sartorius
May 11, 2021
On November 16, 2018, the 13th Zhongshan Forum for Health and Development, co-sponsored by the Government of Zhongshan City and twelve first-level academic societies, was officially opened at the Hilton Hotel Zhongshan.